Latest Biologic Stories
-- SYN-005 Program Targeting Pertussis Toxin to be Highlighted in Oral Presentation -- ROCKVILLE, Md., Aug.
Twenty-five pharmaceutical companies being asked to adopt common principles re biosimilars on patient safety, lobbying and business partnerships. DETROIT, Aug.
-- Executed Agreement with Evonik for Formulation Development, Analytical Services andClinical Drug Manufacturing -- ROCKVILLE, Md., Aug.
-- Oral Presentation to Include Greater Detail on Clinical Outcomes, Including Significant and Unique Improvements in Cognition -- ROCKVILLE, Md., July 31, 2014 /PRNewswire/ -- Synthetic
Step Edits Are the Most Likely Strategy to Drive Use of a Biosimilar Priced 30 Percent Less than the Reference Brand, According to Findings from Decision Resources Group BURLINGTON, Mass.,
MarketOptimizer.org adds “PharmaSphere Regulatory Frameworks and Product Pipelines in the Global Biosimilars Market” to its store.
ROCKVILLE, Md., July 29, 2014 /PRNewswire/ -- Synthetic Biologics, Inc.
BEIJING, July 29, 2014 /PRNewswire/ -- China Biologic Products, Inc.
CARLSBAD, Calif., July 24, 2014 /PRNewswire/ -- Advanced Biologics, currently attending the NASS Summer Spine Meeting in Amelia Island, FL, announced today the publishing of two abstracts
- An imitative word; an onomatopoetic word.